Michael Holder's Insider Trades & SAST Disclosures
Michael Holder's most recent trade in Cytek BioSciences Inc was a trade of 2,908 Common Stock done . Disclosure was reported to the exchange on March 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Michael Holder.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cytek BioSciences Inc | Michael Holder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 2,908 | 6,543 | - | - | Common Stock | |
| Cytek BioSciences Inc | Michael Holder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 2,908 | 19,635 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Michael Holder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 2,181 | 3,635 | - | - | Common Stock | |
| Cytek BioSciences Inc | Michael Holder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 2,181 | 22,543 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Michael Holder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 1,454 | 24,724 | - | - | Restricted Stock Units | |
| Cytek BioSciences Inc | Michael Holder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2024 | 1,454 | 1,454 | - | - | Common Stock | |
| Cytek BioSciences Inc | Michael Holder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 37,878 | 37,878 | - | - | Stock Option (right to buy) | |
| Cytek BioSciences Inc | Michael Holder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 26,178 | 26,178 | - | - | Restricted Stock Units | |
| AVITA Medical Inc | Michael Holder | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 35,950 | 46,450 | - | - | Common Stock | |
| AVITA Medical Inc | Michael Holder | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 20,650 | 20,650 | - | - | Stock Options (Right to Buy) | |
| AVITA Medical Inc | Michael Holder | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2021 | 10,500 | 10,500 | - | - | Common Stock | |
| AVITA Medical Inc | Michael Holder | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2021 | 6,925 | 6,925 | - | - | Stock Options (Right to Buy) | |
| AVITA Medical Inc | Michael Holder | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 112,500 | 112,500 | - | - | Stock Options (Right to Buy) | |
| AVITA Medical Inc | Michael Holder | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2021 | 37,500 | 37,500 | - | - | Stock Options (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges